Amodiaquine Metabolism is Impaired by Common Polymorphisms in CYP2C8: Implications for Malaria Treatment in Africa
- 14 March 2007
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 82 (2), 197-203
- https://doi.org/10.1038/sj.clpt.6100122
Abstract
Metabolism of the antimalarial drug amodiaquine (AQ) into its primary metabolite, N-desethylamodiaquine, is mediated by CYP2C8. We studied the frequency of CYP2C8 variants in 275 malaria-infected patients in Burkina Faso, the metabolism of AQ by CYP2C8 variants, and the impact of other drugs on AQ metabolism. The allele frequencies of CYP2C8*2 and CYP2C8*3 were 0.155 and 0.003, respectively. No evidence was seen for influence of CYP2C8 genotype on AQ efficacy or toxicity, but sample size limited these assessments. The variant most common in Africans, CYP2C8(*)2, showed defective metabolism of AQ (threefold higher K(m) and sixfold lower intrinsic clearance), and CYP2C8(*)3 had markedly decreased activity. Considering drugs likely to be coadministered with AQ, the antiretroviral drugs efavirenz, saquinavir, lopinavir, and tipranavir were potent CYP2C8 inhibitors at clinically relevant concentrations. Variable CYP2C8 activity owing to genetic variation and drug interactions may have important clinical implications for the efficacy and toxicity of AQ.Keywords
This publication has 54 references indexed in Scilit:
- Global and regional burden of disease and risk factors, 2001: systematic analysis of population health dataThe Lancet, 2006
- The global distribution of clinical episodes of Plasmodium falciparum malariaNature, 2005
- Steady-State Pharmacokinetics of Twice-Daily Dosing of Saquinavir Plus Ritonavir in HIV-1–Infected IndividualsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitroAntimicrobial Agents and Chemotherapy, 1991
- Detection of Antidrug IgG Antibodies in Patients with Adverse Drug Reactions to AmodiaquineInternational Archives of Allergy and Immunology, 1991
- The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units.British Journal of Clinical Pharmacology, 1990
- Serious Adverse Drug Reactions to Pyrimethamine-Sulphadoxine, Pyrimethamine-Dapsone and to Amodiaquine in BritainJournal of the Royal Society of Medicine, 1990
- Pharmacokinetics of intravenous amodiaquine.British Journal of Clinical Pharmacology, 1987
- The disposition of amodiaquine in man after oral administration.British Journal of Clinical Pharmacology, 1987
- Amodiaquine-lnduced HepatitisAnnals of Internal Medicine, 1986